Role of Complement in Host Defense against Pneumococcal Otitis Media
- 1 March 2009
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 77 (3) , 1121-1127
- https://doi.org/10.1128/iai.01148-08
Abstract
Strategies to limit complement deposition onStreptococcus pneumoniaeare established as virulence features for invasive disease, but their role in respiratory tract infection requires further analysis. We evaluated complement C3 protein deposition on discordantS. pneumoniaeisolates of the same serotype (6A) and their capacity to cause nasopharyngeal (NP) colonization and experimental otitis media (EOM) in an animal model. We compared C3 binding to five 6A isolates from asymptomatic NP carriers with five 6A strains that caused invasive disease, and we observed less C3 (∼10-fold less fluorescence) binding to invasive isolates. We selected two high-level C3-binding carriage and two low-level C3-binding invasive 6A isolates for further study. In the EOM model, 11/12 (92%) ears challenged with a low-level C3-binding 6A strain became infected. Only 2/8 (25%) ears challenged with the discordant high-level C3-binding 6A isolate developed disease (P= 0.005). Results with the second discordant 6A isolate pair were comparable. Cobra venom factor (CoVF) treatment, which depletes C3 and consumes complement, restored virulence of the high-level C3-binding strain; 8/8 (100%) ears in CoVF-treated animals developed EOM compared to only 25% of ears in naïve animals (P= 0.007). These studies demonstrate the critical role for complement evasion in pneumococcal EOM. Colonization with carriage isolates that bound high levels of C3 caused EOM in fewer animals compared to low-level C3-binding invasive strains. Thus, limiting C3 deposition on the surface ofS. pneumoniaecorrelates with increased incidence of EOM following NP colonization and barotrauma in the animal model.Keywords
This publication has 63 references indexed in Scilit:
- Streptococcus pneumoniaeCapsular Serotype 19F Is More Resistant to C3 Deposition and Less Sensitive to Opsonophagocytosis than Serotype 6BInfection and Immunity, 2009
- Antibody to the Type 3 Capsule Facilitates Immune Adherence of Pneumococci to Erythrocytes and Augments Their Transfer to MacrophagesInfection and Immunity, 2009
- PspA and PspC Minimize Immune Adherence and Transfer of Pneumococci from Erythrocytes to Macrophages through Their Effects on Complement ActivationInfection and Immunity, 2007
- Factor H Binding to PspC ofStreptococcus pneumoniaeIncreases Adherence to Human Cell Lines In Vitro and Enhances Invasion of Mouse Lungs In VivoInfection and Immunity, 2007
- Discovery of a New Capsular Serotype (6C) within Serogroup 6 ofStreptococcus pneumoniaeJournal of Clinical Microbiology, 2007
- Role of Complement in Defense of the Middle Ear Revealed by Restoring the Virulence of NontypeableHaemophilus influenzae siaBMutantsInfection and Immunity, 2007
- The Role of Innate Immune Responses in the Outcome of Interspecies Competition for Colonization of Mucosal SurfacesPLoS Pathogens, 2005
- Genetic Alteration of Capsule Type but Not PspA Type Affects Accessibility of Surface-Bound Complement and Surface Antigens ofStreptococcus pneumoniaeInfection and Immunity, 2003
- A Brief History of the Pneumococcus in Biomedical Research: A Panoply of Scientific DiscoveryClinical Infectious Diseases, 1993
- The Role of Antibody and Complement in the Reticuloendothelial Clearance of Pneumococci from the BloodstreamClinical Infectious Diseases, 1983